G2019s - OmicsDI

Show results for

Unknown (353)
Multiomics (144)
Genomics (59)
Transcriptomics (39)
Proteomics (21)
Other (7)
Metabolomics (1)

Organisms

Homo sapiens (43)
Mycobacterium tuberculosis SP7 (16)
Mycobacterium tuberculosis SP10 (16)
Mycobacterium tuberculosis SP13 (16)
Mycobacterium tuberculosis SP22 (16)
Chlamydomonas reinhardtii (16)
Enterococcus mundtii CRL35 (16)
Oncorhynchus tshawytscha (16)
Pseudomonas canadensis (16)
Pseudomonas aeruginosa PAO1H2O (16)
Human alphaherpesvirus 1 strain 17 (16)
Mycobacterium tuberculosis SP1 (16)
Marchantia polymorpha subsp. ruderalis (16)
Methylocystis sp. (16)
Exiguobacterium sp. SH31 (16)
Palaemonetes sp. common grass shrimp associated circular virus (16)
Amaranthus tricolor (16)
Spirochaeta sp. ELBA (16)
Clavibacter nebraskensis NCPPB 2581 (16)
Porites pukoensis (16)
Porphyromonas gingivalis (16)
Leishmania tarentolae (16)
Porphyromonas gingivalis W83 (16)
Human betaherpesvirus 5 (16)
Bothrops insularis (16)
Bothrops jararaca (16)
Bothrops jararacussu (16)
Mus musculus (11)
Caenorhabditis elegans (1)
synthetic construct (1)

Organisms

Homo sapiens (34)
Mus musculus (13)
Caenorhabditis elegans (1)

Repository

LINCS (147)
ENA (52)
geo (43)
pride (16)
biostudies-arrayexpress (9)
jPOST (1)
MassIVE (1)
MetaboLights (1)
PanoramaPublic (1)

Tissue

Brain (4)
Fibroblast (3)
Neutrophil (3)
Blood (3)
Cell culture (3)
Peripheral blood mononuclear cell (2)
Urine (2)
Kidney (2)
Cerebrospinal fluid (1)
Skin (1)
Bone marrow (1)
Macrophage (1)
Lung (1)

Disease

Parkinson's disease (11)

Technology Type

KINOMEscan (147)
Fluorescence intensity (144)
Mass Spectrometry (16)
Shotgun proteomics (9)
Bottom-up proteomics (5)
QPCR (3)
SRM/MRM (3)
SWATH MS (2)
NMR spectroscopy (1)
Data-independent acquisition (1)
Data-dependent acquisition (1)

Instrument Platform

Q Exactive HF (1)
Nuclear Magnetic Resonance (NMR) - (1)

Publication Date

2015 (74)
2016 (68)
2017 (13)
2022 (9)
2026 (8)
2025 (8)
2012 (7)
2021 (6)
2020 (5)
2013 (4)
2024 (4)
2018 (4)
2023 (3)
2019 (3)
2011 (3)

CHEBI ID

CHEBI:30751 (1)
CHEBI:16199 (1)
CHEBI:16997 (1)
CHEBI:37684 (1)
CHEBI:22652 (1)
CHEBI:17790 (1)
CHEBI:9349 (1)
CHEBI:17170 (1)
CHEBI:18064 (1)
CHEBI:15347 (1)
CHEBI:15366 (1)
CHEBI:16236 (1)
CHEBI:17824 (1)
CHEBI:37084 (1)
CHEBI:60631 (1)
CHEBI:16010 (1)
CHEBI:30794 (1)
CHEBI:28757 (1)
CHEBI:30772 (1)
CHEBI:18295 (1)
CHEBI:46195 (1)
CHEBI:15318 (1)
CHEBI:26806 (1)
CHEBI:17268 (1)
CHEBI:30769 (1)
CHEBI:15354 (1)
CHEBI:35621 (1)
CHEBI:20067 (1)
CHEBI:15344 (1)
CHEBI:32816 (1)

Metabolite Name

Formate (1)
Urea (1)
Pyroglutamate (1)
Propylene glycerol (1)
Fructose (1)
Mannose (1)
Ascorbate (1)
Methanol (1)
Histamine (1)
Dimethyl sulfone (1)
Malonate (1)
Cis-aconitate (1)
Dimethylamine (1)
3-hydroxyisobutyrate (1)
2-oxoglutarate (1)
Acetoacetate (1)
Acetone (1)
Acetaminophen (1)
Butyrate (1)
Acetate (1)
Ethanol (1)
Isopropanol (1)
3-hydroxyisovalerate (1)
2-aminobutyrate (1)
2-hydroxybutyrate pantothenate (1)
2-hydroxyisovalerate (1)
Glycerol (1)
Myo-inositol (1)
Xanthine (1)
Valine (1)

First Public Date

2024 (7)
2025 (6)
2021 (6)
2014 (6)
2026 (5)
2019 (4)
2018 (4)
2016 (4)
2015 (4)
2023 (3)
2022 (1)
2020 (1)
2013 (1)

Study type

Transcription profiling by array (6)
Genotyping by array (1)
ChIP-seq (1)
Proteomic profiling by array (1)

Release Date

2020 (35)
2022 (34)
2024 (32)
2021 (32)
2019 (32)
2023 (31)
2025 (28)
2018 (21)
2017 (20)
2015 (17)
2016 (16)
2012 (15)
2014 (13)
2011 (10)
2013 (8)
2010 (6)
2009 (3)
2005 (3)
2026 (2)
2006 (2)
2007 (1)

Lab affiliation

Medical Research Council (MRC) Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dow Street, Dundee DD1 5EH, United Kingdom (1)
Medical Research Council Protein Phosphorylation and Ubiquitylation Unit, University of Dundee, Dundee, DD1 5EH, UK. (1)
Head of Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany (1)
Head of Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry (1)
Department of Pharmacology, Feinberg School of Medicine, Northwestern University (1)
Kinases and Brain Development Lab, The Francis Crick Institute, England (1)
Department of Structural Biology and Developmental Neurobiology, Center for Proteomics and Metabolomics, St. Jude Children's Research Hospital, Memphis, TN 38105, USA (1)
Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried (1)
Hospital Clinic Barcelona, Spain (1)
Hospital Clinic Barcelona (1)
Laboratory of Neurogenetics, National Institute on Aging, National Institute of Health, Building 35, Room 1A116 35 Convent Drive Bethesda, MD 20814, USA (1)
Turku Bioscience, Abo Akademi and University of Turku (1)
Université de Montréal (1)
Department of Proteomics and Signal Transduction, Max-Planck Institute of Biochemistry, Martinsried, Germany (1)
Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany (1)
Department of Proteomics and Signal Transduction Max Planck Institute of Biochemistry (1)

Previous page
1 / 63
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 63
Next page

Sort by:

Relevance

Page size

Ribosome profiling of G2019S LRRK2 human dopamine neurons

PRJNA354729 | ENA

Modelling G2019S-LRRK2 sporadic Parkinson’s disease in 3D midbrain organoids

PRJNA515615 | ENA

RNA-Seq of LRRK2 G2019S Parkinson’s iPSC-derived astrocytes

PRJNA492470 | ENA

Transcriptome analysis of isogenic Neural stem cell for LRRK2 G2019S mutation.

PRJNA761085 | ENA

The Parkinson's disease associated mutation LRRK2-G2019S affects astrocyte specification

PRJNA552906 | ENA

Differential serum microRNAs in premotor LRRK2 G2019S carriers from Parkinson’s disease

PRJNA914760 | ENA

Genome-wide expression profiling of the LRRK2-G2019S mutation in hNES cells

Parkinson’s disease (PD) has a neuro-developmental component with multiple genetic predispositions. The most prevalent mutation, LRRK2-G2019S is linked to familial and sporadic PD. Based on the multiple origins of PD and the incomplete penetrance of LRRK2-G2019S, we hypothesize that modifiers in the...

ORGANISM(S): Homo sapiens

2018-03-07 | GSE101534 | GEO

Ribosome profiling of G2019S LRRK2 human dopamine neurons

G2019S mutaion of LRRK2 is known to increase mRNA translation. We perform ribosome profiling to study defective translation using human dopamine neuron models. Patient-derived human dopamine neurons with G2019S LRRK2 mutation were generated and used. Also a mutation-corrected isogenic pair line was ...

ORGANISM(S): Homo sapiens

2018-07-01 | GSE90469 | GEO

Gene expression analysis of human iPSC generated from pathogenic LRRK2 (G2019S) mutation bearing patients

Genetic mutations on leucine-rich repeat kinase 2 (LRRK2) have been associated with an increased risk of Parkinson's disease. The Gly2019Ser (G2019S) mutation on LRRK2 gene is a relatively common cause of familial Parkinson's disease in Caucasian population. In this study, we generated human induced...

ORGANISM(S): Homo sapiens

2012-10-17 | E-GEOD-33298 | biostudies-arrayexpress

Modelling G2019S-LRRK2 sporadic Parkinson’s disease in 3D midbrain organoids

Recent advances in generating 3 dimensional (3D) organoid systems from stem cells offer new possibilities for disease modeling. In this study, we generate isogenic 3D midbrain organoids with or without a Parkinson’s disease-associated LRRK2 G2019S mutation. LRRK2-G2019S midbrain organoids derived fr...

ORGANISM(S): Homo sapiens

2019-02-02 | GSE125234 | GEO

Previous page
1 / 63
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 63
Next page

Sort by:

Relevance

Page size

624 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

First Public Date

Study type

Release Date

Lab affiliation

Tags

OmicsDI is part of the ELIXIR infrastructure

Tweets